US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

12  13  14  15    17    19  20  21  
Genovis AB (GENO) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Acorda Therapeutics, Inc. (ACOR) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application (Forensics, Paternity Testing), DNA Amplification, Quantification, Extraction, Services, & Software - Forecast to 2018
5/14/2014 | published by: MarketsandMarkets
... is categorized on the basis of technology, application, product, and geography. The next generation sequencing and rapid DNA analysis market is expected to register the highest growth rate in the human identification market by technology, ...  |  read more...
USD 4,650
Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Deals in Oncology Personalized Medicine Industry – Worldwide Analysis
5/27/2014 | published by: Renub Research
... by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals have been covered under different chapters in below mentioned topics. Collaboration Deals (Chapter No. 2.1) ...  |  read more...
USD 900
Conference Documentation: ADC Summit 2014
5/19/2014 | published by: SMI Publishing, Ltd
... Group is proud to announce that the ADC Summit 2013 conference will be returning to London in 2014. If you are interested in getting involved, please contact Dale Butler on 020 7827 6044 or via email  |  read more...
USD 788.78
Gilead Sciences, Inc. (GILD) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
APEIRON Biologics AG - Product Pipeline Review - 2014
5/30/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of APEIRON Biologics AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Cryo-Save Group N.V. (CRYO) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Celgene Corporation - Product Pipeline Review - 2014
6/10/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Celgene Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
4/22/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Gene Therapy Partnering Terms and Agreements
5/1/2014 | published by: Current Partnering
... in gene therapypartnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value The Gene Therapy Partnering Terms and Agreements report provides an understanding ...  |  read more...
USD 1,995
MetaStat, Inc. (MTST) - Product Pipeline Analysis, 2014 Update
6/26/2014 | published by: GlobalData
... the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat also offers MenaCalc Prostate, a diagnostic for ...  |  read more...
USD 750
Are neurologists ready to embrace gene therapy? - Physician Views
6/11/2014 | published by: FirstWord
... Between the beginning of last year and early April 2014, however, 11 different companies specialising in gene therapy raised $618 million from venture capitalists and the public markets. Momentum for this approach has been driven ...  |  read more...
USD 645
Digital Polymerase Chain Reaction (PCR) Technology: Global Markets
6/1/2014 | published by: BCC Research
... to grow to $489.8 million in 2018, a compound annual growth rate (CAGR) of 28.6% for the five-year period, 2013 to 2018. This report provides: An overview of the global market for digital polymerase chain ...  |  read more...
USD 6,650
CSL Limited - Strategy and SWOT Report
5/29/2014 | published by: MarketLine
... service offerings and corporate actions, providing a 360° view of the company. Features: Detailed information on CSL Limited required for business and competitor intelligence needs A study of the major internal and external factors affecting ...  |  read more...
USD 175
Global Molecular Cytogenetics Market 2014-2018
6/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... Inc. , Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., PerkinElmer Inc., Applied Spectral Imaging Ltd, Biological Industries Ltd, Bio-Rad Laboratories Inc., Cytognomix Inc., CytoTest Inc., Illumina Inc., Kreatech Inc. , Leica Biosystems Ltd, ...  |  read more...
USD 2,500
Fungicides Market by Type (Benzimidazoles, Dithiocarbamates, Phenylamides, Chloronitriles, Strobilurins, Triazoles,), by CROP Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), & by Geography - Global Trends & Forecasts to 2019
6/20/2014 | published by: MarketsandMarkets
... market has grown exponentially in the last few years and this growth is expected to continue. Numerous factors such as high cost of seeds, ease of application, modern production practices, new product offerings, increased availability, ...  |  read more...
USD 4,650
US Dental Biomaterial Market Forecast and Opportunity Assessment : 2006 - 2019
4/24/2014 | published by: ABMRG
... categories covered in this report include: Dental Bone Graft Substitutes Dental Bone Grafts Tissue Regenerative Materials Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, ...  |  read more...
USD 2,100
UK Orthopedic Biomaterial Market Growth and Forecast: To 2019
4/22/2014 | published by: ABMRG
... in this report include: Bone Allografts Demineralized Bone Material (DBM) Bone Graft Substitutes Bone Growth Stimulators Viscosupplementation Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling ...  |  read more...
USD 2,100
Spain Orthopedic Biomaterial Market Forecast and Opportunity Assessment : 2006 - 2019
4/26/2014 | published by: ABMRG
... covered in this report include: Bone Allografts Demineralized Bone Material (DBM) Bone Graft Substitutes Bone Growth Stimulators Viscosupplementation Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average ...  |  read more...
USD 2,100
12  13  14  15    17    19  20  21